P915 - FIBRE CONTAINING ORAL NUTRITIONAL SUPPLEMENTS (ONS) INCREASE TOTAL DAILY FIBRE INTAKE IN ADULTS WITH OR AT RISK OF DISEASE RELATED MALNUTRITION (DRM)

P915

FIBRE CONTAINING ORAL NUTRITIONAL SUPPLEMENTS (ONS) INCREASE TOTAL DAILY FIBRE INTAKE IN ADULTS WITH OR AT RISK OF DISEASE RELATED MALNUTRITION (DRM)

A. Gagnon^1,*, A. O'Callaghan¹, C. Rouws¹, Y. Luiking¹

¹Danone Research & Innovation, Utrecht, Netherlands

 

Rationale: Fibre plays an important role in bowel function¹ which significantly impacts quality of life². Adequate intake (AI) for fibre has been set at 25 g/d³.  Patients with or at risk of DRM have reduced dietary intake overall⁴ and are therefore at risk of failing to meet fibre recommendations.

Methods: A four week, randomized, controlled, single-blind, parallel-group, multi-country study was performed. Patients with medium or high risk of DRM or already taking ONS, received 1-2 servings per day of either a 125 ml ONS, n=25, (Fortimel Compact Fibre®) or 200 ml ONS, n=25, (Fortimel Energy Multifibre®) containing 300 kcal, 12 g protein, and 4.5 g fibre per serving. Dietary intake was assessed by 24 hr dietary recall at baseline (day -1 & -2), day 13 & 14, and day 27 & 28. 

Results: Fibre intake increased over time versus baseline in both groups receiving either 125 ml or 200 ml fibre containing ONS (Table).

	Total Dietary Fibre Intake (g)
Time Point	125 ml ONS	P vs Baseline	200 ml ONS	P vs Baseline	P Between Groups
Baseline	15±1		16±1		0.812
Day 13/14	18±1	0.001	20±1	0.000	0.154
Day 27/28	19±1	0.00	18±2	0.000	0.792

Data as mean ±SEM; Statistics using ANCOVA

Conclusion: Total daily fibre intake of patients requiring ONS was below recommended levels at baseline. Fibre containing ONS are an effective way to increase fibre intake, however, total fibre intake of patients at risk of DRM remained below recommended levels.

References:  

        1. Gill et al. 2021. Nat Rev Gastroenterol Heptaol, 18(2):101-116.

        2. Arco et al. 2022. Gastroenterology, 68(4):397-406.

        3. EFSA. https://efsa.onlinelibrary.wiley.com/doi/epdf/10.2903/j.efsa.2010.1462 [15.03.2025]

        4. Cederholm & Boseaus (2024). N Engl J Med, 391(2):155-165.

Disclosure of Interest: A. Gagnon Other: Employee of Danone Research & Innovation, A. O'Callaghan Other: Employee of Danone Research & Innovation, C. Rouws Other: Employee of Danone Research & Innovation, Y. Luiking Other: Employee of Danone Research & Innovation